Growth Metrics

Moderna (MRNA) Non-Current Debt (2025)

Moderna (MRNA) has disclosed Non-Current Debt for 1 consecutive years, with $590.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Debt changed N/A to $590.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $590.0 million, a N/A change, with the full-year FY2025 number at $590.0 million, changed N/A from a year prior.
  • Non-Current Debt was $590.0 million for Q4 2025 at Moderna.
  • In the past five years, Non-Current Debt ranged from a high of $590.0 million in Q4 2025 to a low of $590.0 million in Q4 2025.